Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction

被引:33
|
作者
Chan, RKM
Lee, KJ
Calafiore, P
Berlangieri, SU
McKay, WJ
Tonkin, AM
机构
[1] AUSTIN & REPATRIAT MED CTR, DEPT CARDIOL, HEIDELBERG, VIC 3084, AUSTRALIA
[2] AUSTIN & REPATRIAT MED CTR, DEPT NUCL MED, HEIDELBERG, VIC 3084, AUSTRALIA
关键词
D O I
10.1016/0735-1097(96)00069-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. The aim of this study was to correlate dobutamine-induced contractile reserve as detected by echocardiography with findings on positron emission tomography in patients with chronic ischemic left ventricular dysfunction, Background. Contractile reserve induced by low dose dobutamine infusion has been proposed as a marker of myocardial viability. Methods. Sixty patients with stable coronary artery disease and left ventricular dysfunction (mean ejection fraction [+/-SD] 29 +/- 10%) underwent transthoracic echocardiography with dobutamine infusion (up to 10 mu g/kg body weight per min) and positron emission tomography with nitrogen-13 ammonia and fluorine-18 (F-18) fluorodeoxyglucose as a perfusion and a metabolic tracer, respectively. Regional wall motion, perfusion and metabolism were analyzed semiquantitatively by using a 16-segment model. Segments with F-18 fluorodeoxyglucose uptake >50% were considered viable on positron emission tomography. Results. After dobutamine infusion, hemodynamic variables changed significantly, and myocardial ischemia was evident in 17 patients, All 60 patients had dysfunctional myocardium considered viable on positron emission tomography (8 +/- 4 segments/patient), whereas 52 patients had dysfunctional myocardium with contractile enhancement by dobutamine echocardiography (4 +/- 2 segments/patient, p = 0.01). The extent of dysfunctional myocardium with contractile reserve appeared to correlate less closely with the total extent of viable dysfunctional myocardium identified by positron emission tomography than with the number of such segments associated with a pattern of perfusion-metabolism mismatch. Conclusions. In patients with chronic ischemic left ventricular dysfunction, echocardiography can be used to identify enhancement in the contractile function of viable dysfunctional myocardium after infusion of low dose dobutamine. In this study, the presence and extent of such enhancement were relatively less than the values obtained from positron emission tomography.
引用
收藏
页码:1601 / 1607
页数:7
相关论文
共 50 条
  • [41] DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN ASSESSMENT OF LEFT-VENTRICULAR DIASTOLIC DYSFUNCTION
    ESQUIVELAVILA, JG
    TEE, H
    CALLAWAY, MJ
    ADKISON, MB
    AHMAD, M
    CLINICAL RESEARCH, 1993, 41 (04): : A721 - A721
  • [42] Perfusable tissue index obtained by positron emission tomography as a marker of myocardial viability in patients with ischemic ventricular dysfunction
    Itoh, H
    Namura, M
    Seki, H
    Asai, T
    Tsuchiya, T
    Uenishi, H
    Fujii, H
    Fujita, S
    Tanabe, Y
    Ito, J
    Shimizu, M
    Mabuchi, H
    CIRCULATION JOURNAL, 2002, 66 (04) : 341 - 344
  • [43] Comparison of echocardiography and radionuclide angiography as predictors of mortality in patients with left ventricular dysfunction (studies of left ventricular dysfunction)
    Rashid, H
    Exner, DV
    Mirsky, I
    Cooper, HA
    Waclawiw, MA
    Domanski, MJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (03): : 299 - 303
  • [44] Head to head comparison of dobutamine-TEE, dobutamine-MRI and positron emission tomography for the prediction of left ventricular functional recovery after revascularization.
    Baer, FM
    Voth, E
    LaRose, K
    Theissen, P
    Crnac, J
    Schmidt, M
    Schneider, CA
    Kettering, K
    Jochims, M
    Schicha, H
    Erdmann, E
    CIRCULATION, 1999, 100 (18) : 161 - 161
  • [45] Prognostic value of dobutamine stress echocardiography in medically treated patients with severe left ventricular dysfunction
    Thamilarasan, M
    Lauer, MS
    Afridi, I
    CIRCULATION, 1999, 100 (18) : 140 - 140
  • [46] The Use of Dobutamine Echocardiography for Recovery Prediction in Cancer Patients with Newly Diagnosed Left Ventricular Dysfunction
    Laeeq, Rida
    Banchs, Jose A.
    Sadek, Nada
    Iliescu, Cezar
    Durand, Jean-Bernard
    Lopez-Mattei, Juan C.
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (08) : S47 - S47
  • [47] Dobutamine stress echocardiography and the effects of trimetazidine on left ventricular dysfunction in patients with coronary artery disease
    Chierchia, SL
    CORONARY ARTERY DISEASE, 2001, 12 : S19 - S21
  • [48] Ischemic and viable myocardium in patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction - A clinical study using positron emission tomography, echocardiography, and electrocardiography
    Yang, H
    Pu, M
    Rodriguez, D
    Underwood, D
    Griffin, BP
    Kalahasti, V
    Thomas, JD
    Brunken, RC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) : 592 - 598
  • [49] Prognostic value of dobutamine echocardiography in patients with coronary artery disease and severe left ventricular dysfunction
    Klaar, U
    Baumgartner, H
    Wutte, M
    Khan, S
    DeRobertis, M
    KongLau, Y
    Siegel, R
    Laufer, G
    Maurer, G
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 91757 - 91757
  • [50] Dobutamine Doppler echocardiography in severe aortic stenosis with left ventricular dysfunction: Comparison with postoperative examination.
    Pop, C
    Metz, D
    Tassan-Mangina, S
    Nazeyrollas, P
    Jamet, B
    Maes, D
    Jennesseaux, C
    Chapoutot, L
    Baehrel, B
    Elaerts, J
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1999, 92 (11): : 1487 - 1493